[1]卞薇,万君丽,谭明琼,等.湿性老年黄斑变性患者治疗期间生存质量及影响因素的纵向研究[J].第三军医大学学报,2018,40(04):356-361.
 BIAN Wei,WAN Junli,TAN Mingqiong,et al.Factors affecting the quality of life in patients during treatment for wet age-related macular degeneration: a longitudinal cohort study[J].J Third Mil Med Univ,2018,40(04):356-361.
点击复制

湿性老年黄斑变性患者治疗期间生存质量及影响因素的纵向研究(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
40卷
期数:
2018年第04期
页码:
356-361
栏目:
临床医学
出版日期:
2018-02-28

文章信息/Info

Title:
Factors affecting the quality of life in patients during treatment for wet age-related macular degeneration: a longitudinal cohort study
作者:
卞薇万君丽谭明琼苏君刘洋李世迎
陆军军医大学(第三军医大学)第一附属医院眼科
Author(s):
BIAN Wei WAN Junli TAN Mingqiong SU Jun LIU Yang LI Shiying

Department of Ophthalmology, First Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, 400038, China

关键词:
老年黄斑变性患者生存质量影响因素纵向研究
Keywords:
age-related macular degeneration treatment period quality of life longitudinal study
分类号:
R195.4;R492;R744.5356
摘要:

目的    采用前瞻性的纵向研究设计,探讨人口学和专科资料以及社会心理因素对老年黄斑变性(age-related macular degeneration,AMD)患者不同治疗期生存质量的影响。方法    采用方便抽样法选取2016年1月至2017年9月就诊于我院门诊的137例AMD患者作为研究对象,分别在治疗后1、3、6个月3个时间点,采用问卷调查对其生存质量及影响因素进行测评。结果    治疗后3个月的生存质量最差,为(54.25±13.37)分,治疗后1个月生存质量最好,为(62.10±15.86)分,且3个不同治疗期的生存质量差异有统计学意义(F=11.518,P=0.000)。对生存质量影响因素的多元逐步回归分析显示:治疗手段(P<0.01)、文化程度(P<0.01)、婚姻状况(P<0.01)、焦虑(P<0.01)、抑郁(P<0.05)、自我效能(P<0.01)、社会支持(P<0.05)和积极应对(P<0.01)是AMD患者生存质量的主要影响因素。结论    AMD患者治疗后6个月中的不同阶段其生存质量及影响因素是动态变化的,为护理人员精准制订多阶段、有针对性的干预措施提供了理论依据。

Abstract:

Objective    To survey the quality of life and the factors affecting the quality of life of patients with age-related macular degeneration (AMD) in different phases of treatment. Methods    The convenience sampling was used for selecting 137 patients with AMD admitted in our department between January, 2016 and September, 2017. Follow-up survey for quality of life of the patients was conducted at 1, 3 and 6 months during the treatment. Results    The mean score for quality of life was the lowest at 3 months (54.25±13.37), and was the highest at 1 month during the treatment (62.10±15.86). Multivariate regression analysis identified the type of disease (P<0.01), education level (P<0.01), marital status (P<0.01), anxiety (P<0.01), depression (P<0.05), selfefficacy (P<0.01), social support (P<0.05) and positive coping style (P<0.01) as the factors that significantly affected the quality of life in the patients during treatment. Conclusion    The factors affecting the quality of life of patients with ADM change with time during the treatment, and multi-staged, targeted interventions of these factors, preferentially within the initial 6 months during treatment, can improve the quality of life among the patients.

参考文献/References:

[1]WONG W L, SU X, LI X, et al. Global prevalence of agerelated macular degeneration and disease burden projection for 2020 and 2040: a systematic review and metaanalysis[J]. Lancet Glob Health, 2014, 2(2): e106-e116. DOI: 10.1016/S2214109X(13)701451.
[2]KARAMPELAS M, PEFKIANAKI M, REES A, et al. Missed hospital appointments of patients receiving ranibizumab therapy for neovascular AgeRelated Macular Degeneration[J]. Ophthalmol Therap, 2015, 4(1): 43-49. DOI: 10.1007/s4012301500315.
[3]YUZAWA M, FUJITA K, TANAKA E, et al. Assessing quality of life in the treatment of patients with agerelated macular degeneration: clinical research findings and recommendations for clinical practice[J]. Clin Ophthalmol, 2013, 7: 1325-1332. DOI: 10.2147/OPTH.S45248.
[4]TAYLOR D J, HOBBY A E, BINNS A M, et al. How does agerelated macular degeneration affect realworld visual ability and quality of life? A systematic review[J]. BMJ Open, 2016, 6(12): e011504. DOI: 10.1136/bmjopen2016011504.
[5]FENWICK E K, CHEUNG G C M, TI GAN A, et al. Change in visionrelated quality of life and influencing factors in Asians receiving treatment for neovascular agerelated macular degeneration[J]. Br J Ophthalmol, 2017. [Epub ahead of print]. DOI: 10.1136/bjophthalmol2017310532.
[6]卞薇, 万君丽, 于文春,等. 湿性老年黄斑变性患者治疗期适应性挑战的现象学研究[J]. 中国护理管理, 2017, 17(10): 13311335.DOI: 10.3969/j.issn.16721756.2017.10.009.
BIAN W, WANG J L, YU W C, et al. A qualitative study on the adaptive challenge of patients with agerelated macular degeneration during therapy[J].Chin Nurs Management, 2017, 17(10): 1331-1335. DOI: 10.3969/j.issn.16721756.2017.10.009.
[7]DEEMER A D, MASSOF R W, ROVNER B W, et al. Functional outcomes of the low vision depression prevention trial in agerelated macular degeneration[J]. Invest Ophthalmol Vis Sci, 2017, 58(3): 1514-1520. DOI: 10.1167/iovs.1620001.
[8]MANGIONE C M, LEE P P, GUTIERREZ P R, et al. Development of the 25item national eye institute visual function questionnaire[J]. Arch Ophthalmol, 2001, 119(7): 1050-1058.
[9]汪向东, 王希林, 马弘. 心理卫生评定量表手册[J]. 中国心理卫生杂志, 1999(增): 31-35, 127-131, 194-197, 235-238.
WANG X D, WANG X L, MA H. Manual of mental health assessment scale[J]. Chin J Mental Health,1999(Suppl): 31-35, 127-131, 194-197, 235238. 
[10]RADLOFF L S. The CESD Scale: A selfreport depression scale for research in the general population[J]. Appl Psychol Meas, 1977, 1(3): 385-401.
[11]解亚宁.简易应对方式量表信度和效度的初步研究[J]. 中国临床心理学杂志, 1998, 6(2): 114-115.
XIE Y N. A preliminary study of the reliability and validity of a simple coping style scale[J]. Chin J Clin Psychol, 1998, 6(2): 114-115.
[12]王才康, 胡中锋, 刘勇. 一般自我效能感量表的信度和效度研究[J]. 应用心理学, 2001, 7(1): 37-40. DOI:  10.3969/j.issn.10066020.2001.01.007.
WANG C K, HU Z F, LIU Y. Evidences for reliability and validity of the chinese version of general selfefficacy scale[J]. Chin J Appl Psychol, 2001, 7(1): 37-40. DOI: 10.3969/j.issn.10066020.2001.01.007.
[13]MCCLOUD C, KHADKA J, GILHOTRA J S, et al. Divergence in the lived experience of people with macular degeneration[J]. Optom Vis Sci, 2014, 91(8): 966-974. DOI: 10.1097/OPX.0000000000000320.
[14]MATAMOROS E, MAUREL F, LON N, et al. Quality of life in patients suffering from active exudative agerelated macular degeneration: the EQUADE study[J]. Ophthalmologica, 2015, 234(3): 151-159. DOI: 10.1159/000433448. 
[15]RYAN B. Models of low vision care: past, present and future[J]. Clin Exp Optom, 2014, 97(3): 209213. DOI: 10.1111/cxo.12157.
[16]IAUDVYTYTE·  L, MITKUTE·  D, BALCˇINIENE·  J. Quality of life in patients with agerelated macular degeneration[J]. Medicina (Kaunas), 2012, 48(2): 109-111.
[17]刘晓静, 邹海东, 吴星伟. 年龄相关性黄斑变性患者视觉相关生存质量变化及相关因素分析[J]. 上海交通大学学报(医学版), 2012, 32(2): 197-201. DOI: 10.3969/j.issn.16748115.2012.02.016.
LIU X J, ZOU H D, WU X W. Visionrelated quality of life and related factors in patients with agerelated macular degeneration[J]. J Shanghai Jiaotong Univ(Med Sci), 2012, 32(2): 197-201. DOI: 10.3969/j.issn.16748115.2012.02.016.
[18]CHATZIRALLI I, MITROPOULOS P, PARIKAKIS E, et al.Risk Factors for Poor Quality of Life among Patients with AgeRelated Macular Degeneration[J]. Semin Ophthalmol, 2017, 32(6): 772-780. DOI: 10.1080/08820538.2016.1181192.
[19]AUGUSTIN A, SAHEL J A, BANDELLO F, et al. Anxiety and depression prevalencerates in agerelated macular degeneration[J]. Invest Ophthalmol Vis Sci, 2007, 48(4): 1498-1503. DOI: 10.1167/iovs.060761.
[20]MUDRAK J, STOCHL J, SLEPICKA P, et al. Physical activity, selfefficacy, and quality of life in older Czech adults[J]. Eur J Ageing, 2015, 13(1): 5-14. DOI: 10.1007/s1043301503521.
[21]REES G, KEEFFE J E, HASSELL J, et al. A selfmanagement program for low vision: program overview and pilot evaluation[J]. Disabil Rehabil, 2010, 32(10): 808-815. DOI: 10.3109/09638280903304193.

相似文献/References:

[1]周山,刘宏,余荣杰,等.肾移植受体93例生存质量调查研究[J].第三军医大学学报,2010,32(15):1652.
 Zhou Shan,Liu Hong,Yu Rongjie,et al.Quality of life in 93 renal transplantation recipients[J].J Third Mil Med Univ,2010,32(04):1652.
[2]曾妍,杨健,况利.伴抑郁症状的慢性丙型肝炎患者的血清BDNF表达与生存质量的相关性分析[J].第三军医大学学报,2011,33(21):2274.
 Zeng Yan,Yang Jian,Kuang Li.Correlation between serum levels of BDNF and life quality in patients with chronic hepatitis C complicated with depressive symptoms[J].J Third Mil Med Univ,2011,33(04):2274.
[3]谭永红,陈洁,向贵平.小组心理干预对恶性肿瘤患者生存质量的影响[J].第三军医大学学报,2011,33(02):186.
 Tan Yonghong,Chen Jie,Xiang Guiping.Group psychological intervention improves survival quality of malignant tumor patients[J].J Third Mil Med Univ,2011,33(04):186.
[4]张隆群,王济明.射频消融与手术切除治疗肝癌并发症及生存率的临床对照研究[J].第三军医大学学报,2007,29(05):457.
 ZHANG Long-qun,WANG Ji-ming.Clinical control study of radio frequency ablation and operation on complications and survival rate of liver cancer[J].J Third Mil Med Univ,2007,29(04):457.
[5]王恩洪,李灿,陈潇,等.视功能问卷和生存质量问卷应用于早中期白内障手术适应证的研究[J].第三军医大学学报,2012,34(10):999.
 Wang Enhong,Li Can,Chen Xiao,et al.Visual function and quality of life questionnaires in operation indications for patients with cataract at early-middle stage[J].J Third Mil Med Univ,2012,34(04):999.
[6]李华,吕莎,张永烨,等.NEI-RQL-42量表中文版对LASIK手术患者生存质量的评价研究[J].第三军医大学学报,2013,35(14):1507.
 Li Hua,Lyu Sha,Zhang Yongye,et al.Evaluation of quality of life after LASIK by Chinese version of NEI-RQL-42 instrument[J].J Third Mil Med Univ,2013,35(04):1507.
[7]黄丽,程婧,吴继雄,等.延续护理对心脏再同步化治疗患者心功能、生存质量和心理状态的影响[J].第三军医大学学报,2014,36(03):292.
[8]林雁娟,许乐,黄惜珍,等.社会支持和认知行为干预对心脏移植患者等待期生存质量的影响[J].第三军医大学学报,2014,36(13):1416.
 Lin Yanjuan,Xu Le,Huang Xizhen,et al.Effects of social support and cognitive behavioral interventions on quality of life in patients awaiting heart transplantation[J].J Third Mil Med Univ,2014,36(04):1416.
[9]卞薇,吴燕,刘洋,等.成人斜视患者生存质量状况及其影响因素调查分析[J].第三军医大学学报,2014,36(22):2312.
 Bian Wei,Wu Yan,Liu Yang,et al.Status and influencing factors of quality of life in strabismus patients[J].J Third Mil Med Univ,2014,36(04):2312.
[10]王庆梅,张明霞,董家鸿,等.肝移植受者生存质量研究[J].第三军医大学学报,2004,26(14):0.[doi:10.16016/j.1000-5404.2004.14.024 ]
 WANG Qing mei,ZHANG Ming xia,DONG Jia hong,et al.[J].J Third Mil Med Univ,2004,26(04):0.[doi:10.16016/j.1000-5404.2004.14.024 ]

更新日期/Last Update: 2018-03-03